Literature DB >> 23639640

Pathology of gastric cancer and its precursor lesions.

Evgeny Yakirevich1, Murray B Resnick.   

Abstract

Gastric cancers are a histologically heterogenous group of neoplasms arising from unique epidemiologic and molecular backgrounds. There is accumulating evidence that the intestinal type of gastric adenocarcinoma develops through a multistep process beginning with chronic gastritis triggered primarily by Helicobacter pylori and progressing through atrophy, intestinal metaplasia, and dysplasia (intraepithelial neoplasia) to carcinoma. Loss of E-cadherin expression resulting from CDH1 gene alterations is the primary carcinogenetic event in hereditary diffuse gastric cancer. Proximal gastric adenocarcinomas likely result from either gastroesophageal reflux or H pylori gastritis. This article provides an update of the histologic, immunohistochemical, and molecular pathways of gastric cancer and its precursors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23639640     DOI: 10.1016/j.gtc.2013.01.004

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  47 in total

Review 1.  Systemic treatment of gastric and esophageal adenocarcinoma in elderly patients.

Authors:  Lodovico Balducci
Journal:  J Gastrointest Oncol       Date:  2015-02

2.  Telomere length is correlated with mitochondrial DNA copy number in intestinal, but not diffuse, gastric cancer.

Authors:  Soo-Jung Jung; Ji-Hyoung Cho; Won-Jin Park; Yu-Ran Heo; Jae-Ho Lee
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

Review 3.  How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.

Authors:  Christina Kim; Karen Mulder; Jennifer Spratlin
Journal:  Oncologist       Date:  2014-08-20

4.  FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration.

Authors:  Gang Cen; Hong-Hua Ding; Bin Liu; Wei-Dong Wu
Journal:  Tumour Biol       Date:  2014-05-28

5.  Hereditary diffuse gastric cancer in two families: A case report.

Authors:  Irene Feroce; Davide Serrano; Roberto Biffi; Bruno Andreoni; Viviana Galimberti; Angelica Sonzogni; Luca Bottiglieri; Edoardo Botteri; Cristina Trovato; Monica Marabelli; Guglielmina Nadia Ranzani; Bernardo Bonanni
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

6.  In Vivo Analysis of the Viable Microbiota and Helicobacter pylori Transcriptome in Gastric Infection and Early Stages of Carcinogenesis.

Authors:  Kaisa Thorell; Johan Bengtsson-Palme; Oscar Hsin-Fu Liu; Reyna Victoria Palacios Gonzales; Intawat Nookaew; Linda Rabeneck; Lawrence Paszat; David Y Graham; Jens Nielsen; Samuel B Lundin; Åsa Sjöling
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 7.  Evolution of Premalignant Disease.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 8.  Biomarkers of Helicobacter pylori-associated gastric cancer.

Authors:  Cara L Cooke; Javier Torres; Jay V Solnick
Journal:  Gut Microbes       Date:  2013-07-12

Review 9.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

10.  Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.

Authors:  Xue Han; Kui Jiang; Bangmao Wang; Lu Zhou; Xin Chen; Shu Li
Journal:  Clin Drug Investig       Date:  2015-10       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.